Does transcatheter aortic valve replacement (TAVR) cause acute and delayed electrophysiologic effects on the atrioventricular conduction system in patients undergoing the procedure?
409 patients undergoing transcatheter aortic valve replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) with continuous ECG and electrophysiologic study (EPS) monitoring
Baseline (pre-TAVR) electrophysiologic parameters
Acute and delayed electrophysiologic effects on the atrioventricular (AV) conduction system (including sinus cycle length, AH and HV intervals, and Wenckebach cycle length)surrogate
TAVR causes significant but often transient peri-procedural AV nodal and His bundle conduction disturbances, suggesting standard pacing criteria like marked HV prolongation may not apply acutely.
BACKGROUND: Conduction disturbances requiring permanent pacing frequently complicate transcatheter aortic valve replacement (TAVR). Understanding of mechanisms causing conduction block is incomplete. OBJECTIVE: To characterize the acute and delayed electrophysiologic effects of TAVR on the atrioventricular (AV) conduction system. METHODS: We conducted a single-center prospective cohort study of 409 patients undergoing TAVR. All patients underwent 12-lead electrocardiography and electrophysiologic study (EPS) immediately before and after valve implantation, with continuous ECG and EP monitoring during the TAVR. Seven patients with AV block underwent repeat EPS 1-12 days after TAVR. RESULTS: TAVR was associated with significant prolongation of sinus cycle length, AH and HV intervals, as well as Wenckebach cycle length (all P100ms) without conduction block occurred in 6.4% of patients during TAVR. Intra-His Wenckebach-type block occurred in 9 patients. In 7 patients with follow-up EPS 1-12 days after TAVR improvement or resolution of AV node and infra-nodal conduction abnormalities was seen in all. CONCLUSIONS: Peri-TAVR conduction disturbances may involve both the AV nodal and His bundle. The usual parameters indicating need for permanent pacing (marked HV prolongation) do not apply to TAVR patients. Distinguishing nodal from infranodal involvement can inform prognosis, anticipated recovery, and pacemaker decision-making, particularly given many conduction abnormalities resolved within 2-4 weeks, supporting a refined post-TAVR risk stratification strategy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Medline et al. (Fri,) studied this question.
synapsesocial.com/papers/6a080cdfa487c87a6a40dacb — DOI: https://doi.org/10.1016/j.hrthm.2026.05.015
Alexandra Medline
Beth Israel Deaconess Medical Center
Jonathan W. Waks
Mount Sinai Beth Israel
Andre D’Avila
Beth Israel Deaconess Medical Center
Heart Rhythm
Building similarity graph...
Analyzing shared references across papers
Loading...